Cargando…

Highly Metastatic Subpopulation of TNBC Cells Has Limited Iron Metabolism and Is a Target of Iron Chelators

SIMPLE SUMMARY: Excess iron is known to be a risk factor of carcinogenesis. Although iron chelators show anti-cancer effects, they have not been used successfully to treat cancer patients. Triple-negative breast cancer (TNBC) is a disease with poor prognosis without effective treatments. Thus, we ai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yuze, Ohara, Toshiaki, Chen, Yuehua, Hamada, Yusuke, Li, Chunning, Fujisawa, Masayoshi, Yoshimura, Teizo, Matsukawa, Akihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856351/ https://www.ncbi.nlm.nih.gov/pubmed/36672419 http://dx.doi.org/10.3390/cancers15020468

Ejemplares similares

Exosomal Wnt7a from a low metastatic subclone promotes lung metastasis of a highly metastatic subclone in the murine 4t1 breast cancer
por: Li, Chunning, et al.
Publicado: (2022)

The chemokine monocyte chemoattractant protein-1/CCL2 is a promoter of breast cancer metastasis
por: Yoshimura, Teizo, et al.
Publicado: (2023)

Expression of Spred2 in the urothelial tumorigenesis of the urinary bladder
por: Oda, Shinsuke, et al.
Publicado: (2021)

Crosstalk between Cancer Cells and Fibroblasts for the Production of Monocyte Chemoattractant Protein-1 in the Murine 4T1 Breast Cancer
por: Imamura, Mayu, et al.
Publicado: (2021)

Spred2 Regulates High Fat Diet-Induced Adipose Tissue Inflammation, and Metabolic Abnormalities in Mice
por: Ohkura, Takahiro, et al.
Publicado: (2019)

Spred2 controls the severity of Concanavalin A-induced liver damage by limiting interferon-gamma production by CD4(+) and CD8(+) T cells
por: Sun, Cuiming, et al.
Publicado: (2021)

A novel, nontoxic iron chelator, super-polyphenol, effectively induces apoptosis in human cancer cell lines
por: Ohara, Toshiaki, et al.
Publicado: (2018)

Thioredoxin interacting protein protects mice from fasting induced liver steatosis by activating ER stress and its downstream signaling pathways
por: Miyahara, Hiroyuki, et al.
Publicado: (2022)

Author Correction: Thioredoxin interacting protein protects mice from fasting induced liver steatosis by activating ER stress and its downstream signaling pathways
por: Miyahara, Hiroyuki, et al.
Publicado: (2022)

Cancer Cell-Derived Granulocyte-Macrophage Colony-Stimulating Factor Is Dispensable for the Progression of 4T1 Murine Breast Cancer
por: Yoshimura, Teizo, et al.
Publicado: (2019)

Decreased miR-200b-3p in cancer cells leads to angiogenesis in HCC by enhancing endothelial ERG expression
por: Moh-Moh-Aung, Aye, et al.
Publicado: (2020)

SPRED2: A Novel Regulator of Epithelial-Mesenchymal Transition and Stemness in Hepatocellular Carcinoma Cells
por: Gao, Tong, et al.
Publicado: (2023)

A Novel Combination Cancer Therapy with Iron Chelator Targeting Cancer Stem Cells via Suppressing Stemness
por: Katsura, Yuki, et al.
Publicado: (2019)

Spred2-deficiency enhances the proliferation of lung epithelial cells and alleviates pulmonary fibrosis induced by bleomycin
por: Kawara, Akina, et al.
Publicado: (2020)

Spred2 Deficiency Exacerbates D-Galactosamine/Lipopolysaccharide -induced Acute Liver Injury in Mice via Increased Production of TNFα
por: Yang, Xu, et al.
Publicado: (2018)

Low prevalence of human mammary tumor virus (HMTV) in breast cancer patients from Myanmar
por: San, Thar Htet, et al.
Publicado: (2017)

Molecular Subtypes of Breast Cancers from Myanmar Women: A Study of 91 Cases at Two Pathology Centers
por: San, Thar Htet, et al.
Publicado: (2017)

Iron Chelators in Treatment of Iron Overload
por: Entezari, Sarina, et al.
Publicado: (2022)

Ovarian stromal cells as a source of cancer-associated fibroblasts in human epithelial ovarian cancer: A histopathological study
por: Fujisawa, Masayoshi, et al.
Publicado: (2018)

Iron chelation and multiple sclerosis
por: Weigel, Kelsey J., et al.
Publicado: (2014)

Iron Chelation in Local Infection
por: Scott, Cassidy, et al.
Publicado: (2021)

Role of Iron Chelators in Mucormycosis
por: Mahalmani, Vidya, et al.
Publicado: (2021)

Conservative Iron Chelation for Neuroferritinopathy
por: Marchand, Felix, et al.
Publicado: (2022)

A Review on Iron Chelators in Treatment of Iron Overload Syndromes
por: Mobarra, Naser, et al.
Publicado: (2016)

Novel Iron Chelators, Super-Polyphenols, Show Antimicrobial Effects against Cariogenic Streptococcus mutans
por: Shinoda-Ito, Yuki, et al.
Publicado: (2023)

Effects of an oral iron chelator, deferasirox, on advanced hepatocellular carcinoma
por: Saeki, Issei, et al.
Publicado: (2016)

Iron Chelator or Iron Supplement Consumption in COVID-19? The Role of Iron with Severity Infection
por: Bastin, Alireza, et al.
Publicado: (2021)

Deferasirox, an oral iron chelator, prevents hepatocarcinogenesis and adverse effects of sorafenib
por: Yamamoto, Naoki, et al.
Publicado: (2016)

Objectives and Methods of Iron Chelation Therapy
por: Hershko, C., et al.
Publicado: (2003)

Iron Chelation Therapy in Thalassemia Syndromes
por: Cianciulli, Paolo
Publicado: (2009)

Iron Chelation Therapy in Myelodysplastic Syndromes
por: Messa, Emanuela, et al.
Publicado: (2010)

Myelodysplastic Syndromes and Iron Chelation Therapy
por: Angelucci, Emanuele, et al.
Publicado: (2017)

Iron chelation in treatment of superficial siderosis
por: Derle, Eda
Publicado: (2018)

Reversing oncogenic transformation with iron chelation
por: Abdelaal, Gina, et al.
Publicado: (2021)

Emerging Roles of the Iron Chelators in Inflammation
por: Di Paola, Alessandra, et al.
Publicado: (2022)

Therapeutic Potential of Iron Chelating Therapy: Modification of Disease by Iron Depletion
por: Hershko, Chaim, et al.
Publicado: (1994)

Iron Chelation Therapy with Deferasirox in the Management of Iron Overload in Primary Myelofibrosis
por: Elli, Elena Maria, et al.
Publicado: (2014)

Korean Guideline for Iron Chelation Therapy in Transfusion-Induced Iron Overload
por: Jang, Jun Ho, et al.
Publicado: (2013)

Iron Pathways and Iron Chelation Approaches in Viral, Microbial, and Fungal Infections
por: Chhabra, Ravneet, et al.
Publicado: (2020)

Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox
por: Amano, Shogo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_noaqmtosoju0dd6r5rpp7rus7t